Topic Review
Bronchopulmonary dysplasia-associated pulmonary hypertension
       Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting preterm infants. More than 50 years after the first description of BPD by Northway, this chronic lung disease affecting many preterm infants is still less understood. Additonally, approximately 40% of preterm infants suffering from severe BPD also suffer from Bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH), leading to a significant increase in total morbidity and mortality. Until today, there is no curative therapy for both BPD and BPD-PH available. It has become increasingly evident that growth factors are playing a central role in normal and pathologic development of the pulmonary vasculature. Thus, this review aims to summarize the recent evidence in our understanding of BPD-PH from a basic scientific point of view, focusing on the potential role of Fibroblast Growth Factor (FGF)/FGF10 signaling pathway contributing to disease development, progression and resolution.
  • 1.1K
  • 26 Aug 2020
Topic Review
The NLRP3 Inflammasome
As a critical component of the innate immune system, the nucleotide-binding and oligomerization domain, leucine-rich repeat, and pyrin domain-containing 3 (NLRP3) inflammasome can be activated by various endogenous and exogenous danger signals. Activation of this cytosolic multiprotein complex triggers the release of the pro-inflammatory cytokines interleukin (IL)-1β and IL-18 and initiates pyroptosis, an inflammatory form of programmed cell death. The NLRP3 inflammasome fuels both chronic and acute inflammatory conditions and is critical in the emergence of inflammaging. Recent advances have highlighted that various metabolic pathways converge as potent regulators of the NLRP3 inflammasome. This review focuses on our current understanding of the metabolic regulation of the NLRP3 inflammasome activation, and the contribution of the NLRP3 inflammasome to inflammaging.
  • 1.5K
  • 24 Aug 2020
Topic Review
Bile Acid Signaling
Bile acids are digestive agents synthesized in the liver and released into the gastrointestinal track during normal physiological conditions to aid in the emulsification of lipids and fat-soluble vitamins. These bile acids are highly regulated via enterohepatic circulation, a process which minimizes bile acid loss through a wide network of organs and bile acid transporters. Beyond this, bile acids and the activation of bile acid receptors has been observed in extrahepatic tissues, in particular the central nervous system. Certain bile acids, through the use of specific bile acid transporters, can also gain entry into the brain via the blood brain barrier. Furthermore, there has been an increase in recent literature highlighting bile acids and the presence of bile acid signaling in the brain and neural cells. This entry is a current overview of these topics.
  • 1.5K
  • 21 Aug 2020
Topic Review
Breast carcinoma eukaryotic initiation factors
Breast cancer is the most frequent neoplasm in females. It is a heterogenous entity, classified into intrinsic subtypes based on gene expression data and in corresponding clinical subtypes based on the determination of hormone receptor expression and proliferative activity estimated from ki67 by immunohistochemistry. As for other tumors, the metabolism of breast tumors depends on aerobic glycolysis ("Warburg-effect") and the capability for effective biosynthesis of proteins. Quantity and quality of protein biosynthesis is mainly controlled in the initiation phase of translation, which is characterized by a complex interaction of eucaryotic initiation factors with the mRNA and ribosomal proteins to form a translationally active ribosome. Thus the eIF subunit composition varies from cancer to cancer and is a key factor for determining the cancer cell´s proteome. eIFs can therefore become a suitable anti-cancer drug target. We here summarize the current knowledge on eIF expression and prognostic impact in breast cancer.
  • 534
  • 11 Aug 2020
Topic Review
Function of platelet lipid rafts
Lipid rafts are dynamic assemblies of glycosphingolipids, sphingomyelin, cholesterol, and specific proteins which are stabilized into platforms involved in the regulation of vital cellular processes. Recent reports have demonstrated that lipid rafts are spatially and compositionally heterogeneous in the single-cell membrane. Sphingomyelin-rich rafts that are spatially and functionally distinct from the cholesterol-rich rafts are found at spreading platelets. Fibrin is translocated to sphingomyelin-rich rafts and platelet sphingomyelin-rich rafts act as platforms where extracellular fibrin and intracellular actomyosin join to promote clot retraction.
  • 903
  • 07 Aug 2020
Topic Review
FAHFAs
Fatty Acid esters of Hydroxy Fatty Acids (FAHFAs) are ester derivatives of fatty acids (FAs) with hydroxy fatty acids (HFAs) carrying the hydroxyl group at different positions. This novel class of endogenously generated lipids, discovered in 2014, has attracted the interest, because such lipids have been found to exhibit anti-diabetic and anti-inflammatory effects. The great number of possible combinations of FAs with HFAs together with the great number of possible positional isomers makes the analysis of FAHFAs very challenging. FAHFAs have been detected and quantified in a variety of human and animal tissues, as well as in plant tissues and foods. Analytical methodologies, either targeted or untargeted, may highly contribute in studying FAHFA levels under various biomedical conditions, and in understanding their role in physiological and pathological conditions.
  • 1.0K
  • 04 Aug 2020
Topic Review
BRCA1 in Centrosome Regulation
Breast cancer gene 1 (BRCA1) is a tumor suppressor associated with hereditary breast and ovarian cancer and forms a heterodimer with BRCA1-associated RING domain protein 1 (BARD1). Centrosomes are the major microtubule-organizing centers in animal cells and are critical for the formation of a bipolar mitotic spindle. BRCA1 and BARD1 localize to the centrosome during the cell cycle, and the BRCA1/BARD1 dimer ubiquitinates centrosomal proteins to regulate centrosome function.
  • 690
  • 03 Aug 2020
  • Page
  • of
  • 161
Video Production Service